C. Bruce Verchere

10.2k total citations · 1 hit paper
163 papers, 7.7k citations indexed

About

C. Bruce Verchere is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, C. Bruce Verchere has authored 163 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Surgery, 81 papers in Genetics and 43 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in C. Bruce Verchere's work include Pancreatic function and diabetes (109 papers), Diabetes and associated disorders (71 papers) and Diabetes Management and Research (25 papers). C. Bruce Verchere is often cited by papers focused on Pancreatic function and diabetes (109 papers), Diabetes and associated disorders (71 papers) and Diabetes Management and Research (25 papers). C. Bruce Verchere collaborates with scholars based in Canada, United States and Netherlands. C. Bruce Verchere's co-authors include Steven E. Kahn, Michael R. Hayden, Clara Westwell‐Roper, Sof Andrikopoulos, Janine K. Kruit, Liam R. Brunham, Kathryn J. Potter, Annette Plesner, Jan A. Ehses and Daniel P. Raleigh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

C. Bruce Verchere

158 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes

2020 459 citations Torsten P. M. Scheithauer, Elena Rampanelli et al. profile →

Peers

Countries citing papers authored by C. Bruce Verchere

Since Specialization

Citations

This map shows the geographic impact of C. Bruce Verchere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bruce Verchere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bruce Verchere more than expected).

Fields of papers citing papers by C. Bruce Verchere

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Bruce Verchere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bruce Verchere. The network helps show where C. Bruce Verchere may publish in the future.

Co-authorship network of co-authors of C. Bruce Verchere

This figure shows the co-authorship network connecting the top 25 collaborators of C. Bruce Verchere. A scholar is included among the top collaborators of C. Bruce Verchere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Bruce Verchere. C. Bruce Verchere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	α cells use both PC1/3 and PC2 to process proglucagon peptides and control insulin secretion 2025 ·Science Advances ·(unknown), (unknown), Sarah M. Gray, Kimberley El, (unknown), Paul A. Grimsrud, Jessica O. Becker, (unknown), Guofang Zhang, Kyle W. Sloop, C. Bruce Verchere, Andrew N. Hoofnagle, David A. D’Alessio, Jonathan E. Campbell	0
2	An INSULIN and IAPP dual reporter enables tracking of functional maturation of stem cell-derived insulin producing cells 2024 ·Molecular Metabolism ·(unknown), Xiao-Qing Dai, Cuilan Nian, Paul C. Orban, C. Bruce Verchere, Patrick E. MacDonald, Francis C. Lynn	1
3	Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes 2024 ·Diabetologia ·Paola S. Apaolaza, Yi‐Chun Chen, (unknown), (unknown), (unknown), C. Bruce Verchere, Teresa Rodríguez-Calvo	1
4	Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes 2023 ·Diabetes Care ·(unknown), Timothy J. McDonald, Richard A. Oram, Pleun de Groen, Elena Rampanelli, Alinda W.M. Schimmel, F. Holleman, Sarah E. Siegelaar, Joost Hoekstra, Catherine B. Brouwer, Filip K. Knop, C. Bruce Verchere, Daniël H. van Raalte, Bart O. Roep, Max Nieuwdorp, Nordin M.J. Hanssen	14
5	Deletion of Carboxypeptidase E in β-Cells Disrupts Proinsulin Processing but Does Not Lead to Spontaneous Development of Diabetes in Mice 2023 ·Diabetes ·Yi‐Chun Chen, (unknown), James Fulcher, Adam Swensen, Xiao-Qing Dai, (unknown), (unknown), (unknown), Annette E. Patterson, Ramon I. Klein Geltink, Patrick E. MacDonald, Weijun Qian, C. Bruce Verchere	9
6	A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models 2023 ·Nature Communications ·(unknown), Fabrice D. Heitz, (unknown), (unknown), Karin Breu, Heather C. Denroche, Julien Thévenet, Melania Osto, Paolo Arosio, Julie Kerr‐Conte, C. Bruce Verchere, François Pattou, Thomas A. Lutz, Marc Y. Donath, Christoph Höck, Roger M. Nitsch, Jan Grimm	13
7	A small molecule improves diabetes in mice expressing human islet amyloid polypeptide 2023 ·Islets ·(unknown), C. Bruce Verchere	3
8	Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes in mice 2023 ·Journal of Clinical Investigation ·Justin A. Spanier, Vivian Fung, (unknown), (unknown), Yixin Chen, (unknown), (unknown), (unknown), (unknown), Jason S. Mitchell, Paul C. Orban, Majid Mojibian, C. Bruce Verchere, Brian T. Fife, Megan K. Levings	33
9	Islet amyloid polypeptide does not suppress pancreatic cancer 2023 ·Molecular Metabolism ·(unknown), Evgeniy Panzhinskiy, Paul C. Orban, Francis C. Lynn, David F. Schaeffer, James D. Johnson, Janel L. Kopp, C. Bruce Verchere	4
10	Elevated islet prohormone ratios as indicators of insulin dependency in auto-islet transplant recipients 2022 ·American Journal of Transplantation ·Yi‐Chun Chen, Agnieszka Klimek‐Abercrombie, Kathryn J. Potter, (unknown), Galina Soukhatcheva, Lei Dai, Melena D. Bellin, C. Bruce Verchere	7
11	Altered β-Cell Prohormone Processing and Secretion in Type 1 Diabetes 2021 ·Diabetes ·Teresa Rodríguez-Calvo, Yi‐Chun Chen, C. Bruce Verchere, Leena Haataja, Peter Arvan, Pia Leete, Sarah J. Richardson, Noel G. Morgan, Weijun Qian, Alberto Pugliese, Mark A. Atkinson, Carmella Evans‐Molina, Emily K. Sims	31
12	Mice lacking PC1/3 expression in POMC-expressing cells do not develop obesity 2021 ·Endocrinology ·(unknown), Surbhi Gahlot, Anne White, C. Bruce Verchere, Malcolm J. Low, Iris Lindberg	5
13	Pancreatic 18F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls 2019 ·PLoS ONE ·Guido J. Bakker, (unknown), Torsten P. M. Scheithauer, C. Bruce Verchere, Erik S.G. Stroes, (unknown), Hilde Herrema, Max Nieuwdorp, Hein J. Verberne, Daniël H. van Raalte	5
14	Neuronal PAS Domain Protein 4 Suppression of Oxygen Sensing Optimizes Metabolism during Excitation of Neuroendocrine Cells 2018 ·Cell Reports ·Paul V. Sabatini, (unknown), Cuilan Nian, Maria M. Glavas, Chi Kin Wong, (unknown), Tatsuya Kin, A. M. James Shapiro, William T. Gibson, C. Bruce Verchere, Francis C. Lynn	17
15	Measurement of Pro-Islet Amyloid Polypeptide (1–48) in Diabetes and Islet Transplants 2017 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Agnieszka Klimek‐Abercrombie, Yi‐Chun Chen, (unknown), (unknown), Cate Speake, Paul C. Orban, Behzad Najafian, Graydon S. Meneilly, Carla J. Greenbaum, Garth L. Warnock, Constadina Panagiotopoulos, C. Bruce Verchere	32
16	Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics 2016 ·eLife ·Andisheh Abedini, Annette Plesner, Ping Cao, Zachary Ridgway, Jinghua Zhang, Ling‐Hsien Tu, Chris T. Middleton, (unknown), Daniel J. Sartori, Fanling Meng, Hui Wang, Amy G. Wong, Martin T. Zanni, C. Bruce Verchere, Daniel P. Raleigh, Ann Marie Schmidt	132
17	miR-33a Modulates ABCA1 Expression, Cholesterol Accumulation, and Insulin Secretion in Pancreatic Islets 2012 ·Diabetes ·Nadeeja Wijesekara, (unknown), Martin H. Kang, Thomas Abraham, Alpana Bhattacharjee, Garth L. Warnock, C. Bruce Verchere, Michael R. Hayden	114
18	Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity 2006 ·Diabetologia ·Jerry Wong, (unknown), James W. Peacock, (unknown), Alice Mui, Stephen W. Chung, Vesna Sossi, Doris J. Doudet, (unknown), T.J. Ruth, Ramon Parsons, C. Bruce Verchere, Christopher J. Ong	68
19	Identification of a Heparin Binding Domain in the N-terminal Cleavage Site of Pro-islet Amyloid Polypeptide 2001 ·Journal of Biological Chemistry ·(unknown), C. Bruce Verchere	83
20	Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro 1994 ·Diabetologia ·C. Bruce Verchere, David A. D’Alessio, Richard D. Palmiter, Steven E. Kahn	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact